CELZ: Creative Medical Technology Holdings Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Creative Medical Technology Holdings Inc (CELZ).
$4.04M Market Cap.
CELZ Market Cap. (MRY)
CELZ Shares Outstanding (MRY)
CELZ Assets (MRY)
Total Assets
$6.67M
Total Liabilities
$327.64K
Total Investments
$0
CELZ Income (MRY)
Revenue
$11.00K
Net Income
-$5.49M
Operating Expense
$5.75M
CELZ Cash Flow (MRY)
CF Operations
-$5.30M
CF Investing
$6.32M
CF Financing
$1.45M
CELZ Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total Assets | $6,669,143 (-37.76%) | $10,715,190 (-44.15%) | $19,186,326 (70.27%) | $11,268,181 (1469.88%) |
Assets Current | $6,135,303 (-40.27%) | $10,270,898 (-45.21%) | $18,747,450 (74.60%) | $10,737,221 (10855.01%) |
Assets Non-Current | $533,840 (20.16%) | $444,292 (1.23%) | $438,876 (-17.34%) | $530,960 (-14.33%) |
Goodwill & Intangible Assets | $530,559 (20.31%) | $441,011 (1.24%) | $435,595 (-17.45%) | $527,679 (-14.86%) |
Shareholders Equity | $6,341,499 (-38.69%) | $10,343,796 (-34.80%) | $15,864,674 (55.27%) | $10,217,740 (125.67%) |
Property Plant & Equipment Net | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cash & Equivalents | $5,940,402 (71.35%) | $3,466,867 (-58.33%) | $8,320,519 (-22.41%) | $10,723,870 (10841.38%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $6,520,191 (-35.31%) | $10,078,617 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $6,520,191 (-35.31%) | $10,078,617 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $2,194 (-66.73%) | $6,594 (-35.31%) | $10,194 (-6.18%) | $10,866 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $2,485 (0%) |
Trade & Non-Trade Payables | $273,530 (-13.79%) | $317,280 (-90.29%) | $3,267,538 (222.92%) | $1,011,862 (23.45%) |
Accumulated Retained Earnings (Deficit) | -$64,591,913 (-9.30%) | -$59,098,432 (-9.82%) | -$53,811,858 (-23.23%) | -$43,667,814 (29.44%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $14,194 (0.00%) | $14,194 (0.00%) | $14,194 (0.00%) | $14,194 (-98.22%) |
Debt Current | $14,194 (0.00%) | $14,194 (0.00%) | $14,194 (0.00%) | $14,194 (-98.22%) |
Debt Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Liabilities | $327,644 (-11.78%) | $371,394 (-88.82%) | $3,321,652 (216.21%) | $1,050,441 (-97.41%) |
Liabilities Current | $327,644 (-11.78%) | $371,394 (-88.82%) | $3,321,652 (216.21%) | $1,050,441 (-97.41%) |
Liabilities Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
CELZ Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Revenues | $11,000 (22.22%) | $9,000 (-89.84%) | $88,600 (0.96%) | $87,754 (-46.65%) |
Cost of Revenue | $4,400 (22.22%) | $3,600 (-87.36%) | $28,491 (-40.58%) | $47,949 (-5.23%) |
Selling General & Administrative Expense | $3,239,232 (-9.02%) | $3,560,309 (-9.72%) | $3,943,543 (33.03%) | $2,964,490 (155.13%) |
Research & Development Expense | $2,400,777 (21.83%) | $1,970,639 (-68.56%) | $6,268,854 (5641.76%) | $109,180 (0%) |
Operating Expenses | $5,750,461 (2.22%) | $5,625,532 (-45.41%) | $10,304,481 (225.50%) | $3,165,754 (157.64%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $4,278,433 (247.96%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$5,493,481 (-3.91%) | -$5,286,574 (47.88%) | -$10,144,044 (-152.80%) | $19,211,768 (152.89%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$5,493,481 (-3.91%) | -$5,286,574 (47.88%) | -$10,144,044 (-152.80%) | $19,211,768 (152.89%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$5,493,481 (-3.91%) | -$5,286,574 (47.88%) | -$10,144,044 (-152.80%) | $19,211,768 (152.89%) |
Weighted Average Shares | $1,480,420 (5.17%) | $1,407,632 (28.76%) | $1,093,204 (319.65%) | $260,506 (349.57%) |
Weighted Average Shares Diluted | $1,480,420 (5.17%) | $1,407,632 (28.76%) | $1,093,204 (236.51%) | $324,862 (460.63%) |
Earning Before Interest & Taxes (EBIT) | -$5,493,481 (-3.91%) | -$5,286,574 (47.88%) | -$10,144,044 (-143.18%) | $23,490,201 (166.93%) |
Gross Profit | $6,600 (22.22%) | $5,400 (-91.02%) | $60,109 (51.01%) | $39,805 (-65.05%) |
Operating Income | -$5,743,861 (-2.20%) | -$5,620,132 (45.14%) | -$10,244,372 (-227.72%) | -$3,125,949 (-180.40%) |
CELZ Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Net Cash Flow from Investing | $6,320,191 (83.45%) | $3,445,185 (134.18%) | -$10,078,617 (0%) | $0 (0%) |
Net Cash Flow from Financing | $1,454,636 (636.86%) | -$270,952 (-101.75%) | $15,472,232 (20.48%) | $12,841,640 (1750.59%) |
Net Cash Flow from Operations | -$5,301,292 (33.96%) | -$8,027,885 (-2.96%) | -$7,796,966 (-251.88%) | -$2,215,782 (-409.90%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $2,473,535 (150.96%) | -$4,853,652 (-101.95%) | -$2,403,351 (-122.62%) | $10,625,858 (113375.63%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $6,520,191 (83.92%) | $3,545,185 (135.18%) | -$10,078,617 (0%) | $0 (0%) |
Capital Expenditure | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | -$2,073,636 (-398.83%) |
Issuance (Purchase) of Equity Shares | $1,454,536 (636.82%) | -$270,952 (-101.75%) | $15,472,232 (4.84%) | $14,758,488 (0%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $36,648 (0.00%) | $36,648 (-46.69%) | $68,746 (-88.45%) | $595,380 (249.56%) |
Depreciation Amortization & Accretion | $110,452 (16.78%) | $94,584 (2.71%) | $92,084 (0.00%) | $92,084 (37.87%) |
CELZ Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Gross Margin | 60.00% (0.00%) | 60.00% (-11.50%) | 67.80% (49.34%) | 45.40% (-34.39%) |
Profit Margin | -49940.70% (14.98%) | -58739.70% (-413.04%) | -11449.30% (-152.30%) | 21892.80% (199.14%) |
EBITDA Margin | -48936.60% (15.17%) | -57688.80% (-408.48%) | -11345.30% (-142.22%) | 26873.20% (226.20%) |
Return on Average Equity (ROAE) | -73.90% (-78.07%) | -41.50% (28.08%) | -57.70% (-105.03%) | 1147.40% (294.57%) |
Return on Average Assets (ROAA) | -70.50% (-75.37%) | -40.20% (25.83%) | -54.20% (-111.29%) | 480.20% (106.79%) |
Return on Sales (ROS) | -49940.70% (14.98%) | -58739.70% (-413.04%) | -11449.30% (-142.77%) | 26768.20% (225.47%) |
Return on Invested Capital (ROIC) | 2890.00% (887.90%) | -366.80% (44.05%) | -655.60% (61.68%) | -1710.70% (-687.26%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -0.62 (49.18%) | -1.23 (-198.30%) | -0.41 (-237.00%) | 0.3 (235.14%) |
Price to Sales Ratio (P/S) | 310.89 (-56.88%) | 721.02 (1433.33%) | 47.02 (-28.33%) | 65.61 (33.99%) |
Price to Book Ratio (P/B) | 0.64 (3.41%) | 0.62 (82.25%) | 0.34 (-78.58%) | 1.58 (491.56%) |
Debt to Equity Ratio (D/E) | 0.05 (44.44%) | 0.04 (-82.78%) | 0.21 (102.91%) | 0.1 (110.12%) |
Earnings Per Share (EPS) | -3.71 (1.33%) | -3.76 (59.48%) | -9.28 (-112.59%) | 73.7 (111.76%) |
Sales Per Share (SPS) | 0.01 (16.67%) | 0.01 (-92.59%) | 0.08 (-75.96%) | 0.34 (-88.13%) |
Free Cash Flow Per Share (FCFPS) | -3.58 (37.21%) | -5.7 (20.04%) | -7.13 (16.15%) | -8.51 (-13.43%) |
Book Value Per Share (BVPS) | 4.28 (-41.70%) | 7.35 (-49.37%) | 14.51 (-63.00%) | 39.22 (105.71%) |
Tangible Assets Book Value Per Share (TABVPS) | 4.15 (-43.18%) | 7.3 (-57.45%) | 17.15 (-58.40%) | 41.23 (2338.14%) |
Enterprise Value Over EBIT (EV/EBIT) | 0 (0%) | 1 (-50.00%) | 2 (100.00%) | 1 (0%) |
Enterprise Value Over EBITDA (EV/EBITDA) | 0.41 (-61.90%) | 1.08 (-34.91%) | 1.65 (136.14%) | 0.7 (244.93%) |
Asset Turnover | 0 (0.00%) | 0 (-80.00%) | 0.01 (-77.27%) | 0.02 (-93.12%) |
Current Ratio | 18.73 (-32.29%) | 27.66 (389.99%) | 5.64 (-44.79%) | 10.22 (511000.00%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$5,301,292 (33.96%) | -$8,027,885 (-2.96%) | -$7,796,966 (-251.88%) | -$2,215,782 (-409.90%) |
Enterprise Value (EV) | -$2,207,375 (60.50%) | -$5,588,659 (66.36%) | -$16,611,719 (-200.65%) | $16,504,668 (-2.48%) |
Earnings Before Tax (EBT) | -$5,493,481 (-3.91%) | -$5,286,574 (47.88%) | -$10,144,044 (-152.80%) | $19,211,768 (152.89%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$5,383,029 (-3.68%) | -$5,191,990 (48.35%) | -$10,051,960 (-142.63%) | $23,582,285 (167.32%) |
Invested Capital | -$115,268 (-101.79%) | $6,450,112 (-9.44%) | $7,122,754 (798.57%) | -$1,019,615 (97.43%) |
Working Capital | $5,807,659 (-41.33%) | $9,899,504 (-35.83%) | $15,425,798 (59.25%) | $9,686,780 (123.96%) |
Tangible Asset Value | $6,138,584 (-40.25%) | $10,274,179 (-45.21%) | $18,750,731 (74.58%) | $10,740,502 (10858.35%) |
Market Capitalization | $4,038,869 (-36.61%) | $6,371,601 (18.77%) | $5,364,457 (-66.73%) | $16,121,868 (0.48%) |
Average Equity | $7,435,140 (-41.67%) | $12,746,760 (-27.51%) | $17,583,620 (950.18%) | $1,674,342 (113.40%) |
Average Assets | $7,791,586 (-40.73%) | $13,146,414 (-29.72%) | $18,705,669 (367.52%) | $4,001,070 (678.70%) |
Invested Capital Average | -$190,086 (-113.19%) | $1,441,143 (-6.86%) | $1,547,305 (212.69%) | -$1,373,120 (88.60%) |
Shares | 1,748,428 (26.50%) | 1,382,126 (-1.81%) | 1,407,625 (92.96%) | 729,496 (532.00%) |